Get started
Author

J. Spapens

Observed names: Jeltje C C Spapens, Jeltje CC Spapens, Jeltje Spapens
ORCID: 0009-0008-8239-6761
Observed ORCID: 0009-0008-8239-6761
OpenAlex ID: A5092927759
Multicenter retrospective study on perceived effectiveness, reported side effects, and cognitive outcomes of SSRIs in 22q11.2 deletion syndrome
2026 · Caren Latrèche, Valentina Mancini, et al. · European Child & Adolescent Psychiatry · 2
PDF
Effects of riluzole on excitation-inhibition imbalance and functional connectivity in 22q11.2 deletion syndrome: a multimodal 7-Tesla MRI study
2026 · Amy L Sylvester, Jeltje CC Spapens, et al. · Psychiatry Research Neuroimaging
Striatal dopamine function in 22q11.2 CNVs: Insights from a DAT SPECT study
2026 · J. Spapens, C.F.M. van Hooijdonk, et al. · Neuroscience Applied
Modulating neural excitation-inhibition balance to treat psychotic and cognitive symptoms in 22q11.2 deletion syndrome
2026 · A. Sylvester, J. Spapens, et al. · Neuroscience Applied
Striatal dopamine transporter binding in adults with 22q11.2 copy number variants: a SPECT study
2026 · Jeltje C C Spapens, Carmen F van Hooijdonk, et al. · Brain Communications
PDF
EP18.19: Serum placental biomarkers can predict maternal and neonatal morbidity and a shorter interval to delivery in women with pre‐eclampsia
2023 · M. Suiters, J. Spapens, et al. · Ultrasound in Obstetrics and Gynecology
PDF
PO6_13. Maternal biomarkers as a predictor for neonatal outcomes and timing of delivery
2023 · M. Suiters, M. Hendrix, et al. · Pregnancy Hypertension
Works count: 7
Citation count: 2
H-index: 1
I10-index:
Year
Topic
Type